- Home
- GAME vs INMB Comparison
GAME vs INMB Comparison
Compare GAME & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GAME | INMB |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 39.6M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GAME | INMB |
|---|---|---|
| Price | $0.39 | $1.99 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 849.5K | ★ 1.1M |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.14 | 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $44,999,302.00 | $50,000.00 |
| Revenue This Year | $87.12 | N/A |
| Revenue Next Year | $21.14 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.24 | $1.09 |
| 52 Week High | $1.44 | $3.24 |
Technical Indicators
Market Signals| Indicator | GAME | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 64.89 |
| Support Level | $0.37 | $1.21 |
| Resistance Level | $0.48 | $2.30 |
| Average True Range (ATR) | 0.03 | 0.17 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 81.72 | 72.00 |
Price Performance
Historical ComparisonAbout GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.